Welcome to our dedicated page for 3-D Sys Del news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3-D Sys Del stock.
About 3D Systems
3D Systems Corporation (NYSE:DDD) has been a transformative force in the manufacturing industry for over three decades. With a legacy rooted in pioneering 3D printing, the company has continually redefined what is possible in additive manufacturing by providing a comprehensive suite of digital design and fabrication solutions. Its offerings span advanced 3D printers, an extensive range of materials—including plastics, metals, ceramics, and edibles—and integrated software platforms that connect design, simulation, and production. This cohesive ecosystem empowers industrial and healthcare customers to transform concepts into tangible, high-precision products.
Advanced 3D Printing and Additive Manufacturing Solutions
At the core of 3D Systems' business is a commitment to innovation in additive manufacturing and digital design. The company’s cutting-edge 3D printing hardware and cloud-driven manufacturing services allow for precise fabrication of complex parts. This includes high-quality production for industries that demand rigorous standards, such as aerospace, automotive, and defense. Its portfolio of technologies not only improves production speed and efficiency but also reduces material waste and costs by enabling advanced design techniques and streamlined processes.
Healthcare Solutions and Digital Dentistry
3D Systems has made significant inroads into the healthcare sector by offering personalized medical solutions that enhance patient outcomes. Its digital dentistry innovations, notably the FDA-cleared multi-material jetted denture solution, enable dental laboratories to produce aesthetic and durable dentures with high efficiency. Additionally, its comprehensive approach to personalized healthcare now includes simulation, surgical planning, and the production of patient-specific medical devices. This integration of precision engineering and medical expertise directly supports enhanced surgical workflows and improved patient care.
Industrial Integration and Investment Casting
Within the industrial sector, 3D Systems addresses traditional manufacturing challenges with innovative techniques. Its proprietary QuickCast Air tool optimizes the production of investment casting patterns by reducing material consumption, accelerating build times, and lowering overall costs. By converting standard casting methods into a digitally driven process, the company enables manufacturers in high-demand industries—such as aerospace, energy, and automotive—to produce high-precision components with reduced lead times and significantly enhanced design flexibility.
Software Platforms and Workflow Integration
Complementing its hardware, 3D Systems leverages robust software solutions that redefine manufacturing workflows. Platforms like 3D Sprint and 3DXpert simplify the transition from computer-aided design to final production, automating repetitive tasks and integrating quality inspection protocols. The Oqton Manufacturing OS further exemplifies this integration by optimizing factory-floor operations across multiple manufacturing sites. These platforms not only foster an efficient design-to-production process but also incorporate advanced simulation tools and traceability features essential for regulated environments.
Global Impact and Technological Expertise
Operating throughout the Americas, EMEA, and APAC, 3D Systems has established a far-reaching global presence. Its expansive network of offices and facilities supports a diverse customer base, ensuring that innovative digital manufacturing solutions are accessible worldwide. The company’s continual investment in research and development has reinforced its position as a trusted partner in high-criticality markets. By addressing cost pressures, elevating production quality, and reducing time-to-market, 3D Systems serves as a critical enabler of modern manufacturing across multiple sectors.
Strategic Market Position and Industry Innovation
3D Systems differentiates itself in a competitive landscape by combining decades of experience with ongoing technological innovation. Its business model integrates hardware excellence with sophisticated software and material science, which collectively enhance automation and production efficiency. This comprehensive approach has allowed 3D Systems to set industry benchmarks, facilitating high-volume, precise manufacturing while navigating the challenges inherent in traditional production methods. Through its collaborative mindset with both customers and strategic partners, 3D Systems continues to shape the future of digital manufacturing and secure its role as a cornerstone of the modern industrial ecosystem.
3D Systems (NYSE:DDD) has announced the launch of a new biotech company, Systemic Bio, aimed at revolutionizing drug development by leveraging advanced bioprinting technologies. The company will utilize its proprietary h-VIOS™ organ-on-a-chip platform to create vascularized human tissues for drug testing, potentially reducing costs and the reliance on animal testing. Initial seed funding of $15 million is provided, with expected revenues nearing $100 million annually within five years. Taci Pereira is appointed as CEO, bringing extensive experience in bioengineering.
3D Systems has partnered with HII to develop the copper-nickel alloy CuNi30, designed for direct metal printing. This innovation can potentially reduce lead times by up to 75%, addressing the needs in marine, offshore oil & gas, and chemical industries. The alloy boasts an average relative density of 99.88%, significantly surpassing traditional casting methods. CuNi30 will be available in Q4 2022, enhancing supply chain efficiency while minimizing inventory costs. This advancement could revolutionize manufacturing processes in sectors requiring corrosion-resistant materials.
3D Systems (NYSE:DDD) has appointed Dr. Toby Cosgrove and Dr. Bon Ku to its Medical Advisory Board, expanding its expertise in regenerative medicine. Dr. Cosgrove, former CEO of the Cleveland Clinic, brings extensive healthcare leadership and innovation experience. Dr. Ku, a leader in healthcare technology, directs the Health Design Lab at Thomas Jefferson University. Their appointments aim to enhance 3D Systems' growth in areas like human tissue printing and medical device innovation. Both professionals are expected to contribute significantly to the company’s strategic direction.
3D Systems Corporation (NYSE: DDD) reported Q2 2022 financial results, with revenue of $140.0 million, a 13.8% decline from Q2 2021. Non-GAAP revenue, excluding divestitures, increased 7.8% due to robust demand in Industrial and Healthcare sectors, despite supply chain issues. The company posted a diluted GAAP loss per share of $0.26. Cash reserves stand at $638.2 million. FY 2022 revenue guidance has been lowered to $530 million - $570 million, citing foreign exchange impacts and decreased customer spending.
3D Systems (NYSE:DDD) announced the appointment of Michael Turner as Executive Vice President and Chief Financial Officer, effective August 29, 2022. Turner, who brings over 20 years of financial expertise, previously served as CFO at Innovative Chemical Products and held various finance leadership roles at Albemarle Corporation. His experience includes driving financial controls and implementing technology-based strategies. CEO Dr. Jeffrey Graves expressed enthusiasm for Turner's impact on the company's growth trajectory. Wayne Pensky is recognized for his interim leadership during the transition.
3D Systems has collaborated with Fleet Space Technologies to develop RF patch antennas for their Alpha satellite constellation. Utilizing the DMP Flex 350 printer, Fleet Space will produce antennas in-house, significantly enhancing production efficiency. The development process, requiring only three weeks for small batch production, leverages advanced additive manufacturing techniques. This partnership aims to improve global connectivity and support sustainable mineral exploration. The DMP Flex 350 allows for precise manufacturing, reducing signal loss and operational costs.
3D Systems (NYSE:DDD) will announce its second quarter 2022 financial results on August 8, 2022, after U.S. market close. The company has scheduled a conference call and webcast for August 9, 2022, at 8:30 a.m. ET to discuss these results. Investors can access the webcast at 3D Systems Investor Relations. This event marks an important opportunity for stakeholders to gain insights into the company's performance and outlook.
3D Systems and EMS-GRILTECH have launched DuraForm® PAx Natural, a pioneering nylon copolymer for Selective Laser Sintering (SLS) platforms. Designed for high-impact and elongation applications, it operates at low temperatures (120°C), enhancing printing efficiency and reducing time to delivery. As the exclusive distributor, 3D Systems reports that this eco-friendly material can increase production throughput and minimize waste, featuring over five years of indoor stability. Early adopters commend its performance, highlighting a shift in the cost structure for SLS technology.
3D Systems has appointed Dr. David J. Shulkin, former U.S. Secretary of Veterans Affairs, to its newly formed Medical Advisory Board. The board's mission is to enhance the company's initiatives in regenerative medicine. Dr. Shulkin, noted for his leadership in healthcare management, aims to guide 3D Systems in expanding its Healthcare Solutions business, primarily focusing on dental and orthopedic applications. His experience in patient-centered care is expected to bolster the company's strategic direction in applying 3D printing technologies in medicine.
United Therapeutics and 3D Systems Corporation have unveiled the world's most complex 3D-printed object – a human lung scaffold – at the LIFE ITSELF Conference in San Diego. The scaffolds, demonstrating gas exchange in animal models, consist of 44 trillion voxels with extensive pulmonary structures and are expected to enter human clinical trials within five years. Additionally, current methods extend the viability of human donor lungs, enhancing transplant availability. This initiative aligns with United Therapeutics’ goal to create an unlimited supply of transplantable organs.
FAQ
What is the current stock price of 3-D Sys Del (DDD)?
What is the market cap of 3-D Sys Del (DDD)?
What core solutions does 3D Systems provide?
How does 3D Systems support the healthcare industry?
What role does additive manufacturing play in their offerings?
How does the company address industrial manufacturing challenges?
What software platforms are integral to 3D Systems' operations?
How does 3D Systems ensure quality and regulatory compliance?
What industries benefit most from 3D Systems' technologies?
What distinguishes 3D Systems in the competitive digital manufacturing market?
